Article
Cell-of-Origin, not Oncogenic Effect, Determines Desmoplastic Immune Exclusion in KRAS-Driven Liver Cancer
2026-03-26
Abstract excerpt
Intrahepatic cholangiocarcinoma (iCCA) and hepatocellular carcinoma (HCC) are the two most common primary liver cancers and share common risk factors. Yet they exhibit distinct oncogenic driver landscapes and fundamentally different tumor microenvironments (TME), with iCCA characterised by dense desmoplastic stroma that limits therapeutic efficacy. Whether these differences reflect oncogenic context or the develop...
Topics
Open a Topic to create a Post that cites this publication.
- Cancer Immunotherapy and Biomarkers
- Cancer-related molecular mechanisms research
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Glycosylation and Glycoproteins Research
- MicroRNA in disease regulation
- Pediatric Hepatobiliary Diseases and Treatments
- Peptidase Inhibition and Analysis
- RNA modifications and cancer
Identifiers and source
- Literature Corpus work
- 2cb5c7bf-6059-553c-9f75-732e4489297d
- DOI
- 10.64898/2026.03.24.711280
